|
HSD17B4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.639600E-03 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.523300E-03 |
| Stage1-vs-Stage3 |
3.566400E-02 |
| Stage1-vs-Stage4 |
9.239900E-04 |
| Stage2-vs-Stage3 |
2.170800E-04 |
| Stage2-vs-Stage4 |
1.7015499999995E-05 |
| Stage3-vs-Stage4 |
2.305400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.54359996690823E-09 |
| Normal-vs-Asian |
9.99200722162641E-16 |
| Caucasian-vs-AfricanAmerican |
8.083000E-01 |
| Caucasian-vs-Asian |
4.916600E-01 |
| AfricanAmerican-vs-Asian |
4.858200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29340982368831E-13 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.182000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.96065386148803E-13 |
| Normal-vs-Age(61-80Yrs) |
1.62547753035369E-12 |
| Normal-vs-Age(81-100Yrs) |
6.23140000000078E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.064400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.975600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.488200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.410000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.210200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.535000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.68929999999823E-05 |
| Classical-VS-Follicular |
7.50490000145376E-08 |
| Classical-VS-Other |
7.117400E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
2.15882867138362E-12 |
| Tall-VS-Other |
1.635640E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
1.514840E-01 |
| Follicular-VS-Normal |
3.151100E-04 |
| Other-VS-Normal |
6.159400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29807276039173E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.83870000000686E-05 |
|
|
